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Abstract
Background: The goal of this Geographic Information System (GIS) study was to obtain accurate information on
the locations of study subjects, road network and services for research purposes so that the clinical outcomes of
interest (e.g., vaccine efficacy, burden of disease, nasopharyngeal colonization and its reduction) could be linked
and analyzed at a distance from health centers, hospitals, doctors and other important services. The information on
locations can be used to investigate more accurate crowdedness, herd immunity and/or transmission patterns.
Method: A randomized, placebo-controlled, double-blind trial of an 11-valent pneumococcal conjugate vaccine
(11PCV) was conducted in Bohol Province in central Philippines, from July 2000 to December 2004. We collected
the information on the geographic location of the households (N = 13,208) of study subjects. We also collected a
total of 1982 locations of health and other services in the six municipalities and a comprehensive GIS data over the
road network in the area.
Results: We calculated the numbers of other study subjects (vaccine and placebo recipients, respectively) within
the neighborhood of each study subject. We calculated distances to different services and identified the subjects
sharing the same services (calculated by distance). This article shows how to collect a complete GIS data set for
human to human transmitted vaccine study in developing country settings in an efficient and economical way.
Conclusions: The collection of geographic locations in intervention trials should become a routine task. The results
of public health research may highly depend on spatial relationships among the study subjects and between the
study subjects and the environment, both natural and infrastructural.
Trial registration number: ISRCTN: ISRCTN62323832
Background
Many vaccine trials have been based on individual ran-
domization with an assumption that factors affecting
vaccine efficacy is balanced. More precisely, this
assumption presumes a random distribution of the
environment and population as well as an equal force of
infection among vaccinated and control subjects. The
spatial distributions of vaccine and control recipients are
assumed to be random. Clustering due to varying vac-
cine coverage in the immediate neighborhood is usually
not considered. To measure the spatio-temporal effects
of vaccination the time-dependent process of vaccina-
tion needs to be related to the location of the study
subjects. Emch et al. [1] showed that vaccine efficacy
may show considerable variation locally. For example,
variation in the density of population may influence
transmission rates and thus the measures of vaccine effi-
cacy [2]. In addition, Moïsi et al. [3] have shown that
the vaccination status of the population not attending to
the trial should also be considered. In reality, few vac-
cine trials are measuring pure direct vaccine efficacy.
More often vaccine efficacy is impacted by hard to con-
trol for factors which may have spatio-temporal dimen-
sions. These factors include for example herd immunity,
local epidemics and population density. The main out-
come of trials in such circumstances is better defined as
vaccine effectiveness.
The endpoints of interest measured in vaccine trials
are often obtained via passive surveillance systems that
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illness. Access to care varies locally and this can affect
the rate and/or severity of symptoms recorded in the
study subjects. One measure of access is the travel effort
[4,5] or the geographic distance to health services [6].
Results may also be affected by the local socio-economic
conditions, women’ss o c i a ls t a t u s[ 7 ]o rp a t t e r n so f
health behavior. Some of these factors may depend on
the spatial factors such as crowdedness. Thus, the
human-to-human transmission potential of pathogens
may be locally higher close to the services, and this
needs to be taken into account when interpreting results
of trials and other intervention studies.
To enhance the understanding and appreciation on
how to obtain and utilize spatial data in a trial context,
we describe the Acute Respiratory Infection Vaccine
(ARIVAC) consortium experience. Geographic Informa-
tion System (GIS) data were collected from the area
where a phase III trial, i.e. an individual-randomized,
placebo-controlled, double-blind efficacy trial of an
investigational 11-valent pneumococcal conjugate vac-
cine (11PCV; ISRCTN 62323832) was carried out. The
trial was conducted in 6 municipalities (Tagbilaran City,
Dauis, Panglao, Baclayon, Cortes, and Balilihan) in
Bohol Province of the central Philippines, from July
2000 to December 2004 [8], in children aged from 6
weeks to 6 months. The primary objective of the core
trial was to determine the vaccine efficacy (VE) against
the first episode of radiologically confirmed pneumonia
in the first 2 years of life. Infants and children under 2
years of age, who lived in the same study areas but were
not enrolled in the core trial, were part of an epidemio-
logical study. Here we describe the process of creating
reliable GIS data in a setting of a resource poor country
without existing spatial information. This data will be
used to answer various a posteriori research questions
that may arise in the vaccine trials.
Methods
GIS data were collected to obtain information on the
location of the households of study subjects in the core
trial (both 11PCV and placebo recipients) and in the
epidemiological study. The 6 municipalities were divided
into 48 smaller administrative units called barangays.
Information on the locations of barangay (village or city
district) health stations, health centers, hospitals and
other landmarks as well as the road network in the six
municipalities was obtained. The data were collected
from November 2008 to June 2009. We used Arc/Info
Workstation (ESRI Inc.) for the GIS calculations, Mani-
fold 8 http://www.manifold.net for the spatial illustra-
tions and SPSS 17 (SPSS Inc.) and SAS 9.2 (SAS
Institute Inc.) for the statistical calculations. The GIS
study was part of the Herd immunity sub-study protocol
and along with the core trial was approved by the ethics
review board of the Research Institute for Tropical
Medicine (RITM), Philippines and of National Institute
for Health and Welfare (THL), Finland.
Field data collection
The location of the birth addresses of 12,194 children
enrolled in the efficacy trial and the 577 children
enrolled in the epidemiological study were collected
with a hand-held Global Positioning System (GPS) unit
Magellan Triton 500
R, marking a waypoint at each loca-
tion. If the child moved before the age of 2 years, an
additional waypoint was collected. Six field workers
trained to use the GPS units and the Vantagepoint soft-
ware collected the waypoints. A pre-completed collec-
tion form was prepared from the trial database to guide
the field worker in locating households where the chil-
dren lived at birth and at 2 years of age. The form con-
tained the demographic information of the child, the
maiden name of the mother, the address of the house-
hold at the time of enrolment, whether the child com-
pleted or was withdrawn from the trial, and any
amendments to the information of the child after enrol-
ment. The form was also used to input the GIS data
(latitude and longitude), whether the waypoints were the
exact locations at birth and at 2 years of age, to com-
plete the coordinates saved in the GPS hand held unit
and to have a paper backup. The location of the house-
hold was confirmed by the mother or family members
and by neighbors, if the family was not available or had
moved. If it was not possible to measure the exact loca-
tion accurately, the place was flagged as an estimate in
the collection form. If the child moved out from the
study area and transferred to a different location, the
field worker attempted to determine the new location.
The field worker wrote the household waypoints and
relevant information on the collection form for
documentation.
Besides the locations of the households of the study
children, relevant landmarks such as hospitals, health
stations, health care providers, schools, offices and busi-
nesses where people spend their time outside their
home were also collected. The road networks were col-
lected with no classification to major or minor ones.
During the first visits to the barangays, the field
worker introduced themselves to the heads of the baran-
gay and informed them of the activities to be done.
They also gathered some general information about the
area, such as the number of barangay health workers
(BHWs), number of establishments, and the availability
of private healthcare providers. The field worker also
solicited the help of the BHWs who were familiar with
the area, location of the households and information
regarding the families. Some of them were also involved
Tanskanen et al. BMC Research Notes 2012, 5:51
http://www.biomedcentral.com/1756-0500/5/51
Page 2 of 9in recruitment and enrolment of the children to the ori-
ginal trial.
Depending on the area, the field worker either col-
lected the information alone, in pairs with a colleague
or accompanied by the BHW. Field work was done
municipality by municipality. Approximately 50% of the
children enrolled to the core trial resided in the capital
of the province, Tagbilaran City.
The waypoints for certain landmarks, such as schools
and health services, were collected simultaneously with
the household data. Each landmark was assigned a spe-
cific type. There was no decent roadmap available of the
study area. To get the GPS tracks of the roads, the field
worker either rode a motorcycle or walked through the
roads. The GPS tracks were saved as trails when the
tracking ended or if the GPS lost satellite connection.
After each working day, the field worker transferred
the GIS data from the GPS to a dedicated computer in
the project office. Every Monday, data accompanied
with a weekly report of the field activities were trans-
mitted to the Research Institute for Tropical Medicine
(RITM), Manila. The weekly reports included status of
completion, problems encountered and updates on the
waypoints previously collected.
We used a given naming practice for the waypoints,
landmarks and trails. The waypoint identification (ID)
from the GPS unit was a running number from 001 after
every reset of GPS, which was done daily. Since this kind
of numbering was difficult to identify, we replaced it by
the child identification number assigned to the child at
the time of trial enrolment. If a different waypoint was
collected for the child at the age of 2 years, the identifica-
tion number was appended with the letter ‘A’. If the child
moved to a different location before reaching the age of 2
years, the waypoint ID was appended with the letter ‘B’.
A unique codename was assigned to each unique land-
mark. The naming practice was based on the landmark
types (Table 1) followed by the municipality and baran-
gay identification numbers, a three digit chronological
number and the field worker ID of the person who col-
lected the landmark points. The trail names started with
letter ‘T’ that was followed by the municipality and bar-
angay identification numbers, a three digit chronological
number and the field worker ID of the person who col-
lected the trail waypoints.
The study also collected a barangay profile to obtain
information about the overall economic level, social wel-
fare level, population and services available in the baran-
gay. The respondents were the barangay captain,
barangay councilor or BHW.
In addition to the 6 fieldworkers, the study involved
one GIS officer in Bohol, one GIS officer in RITM, Man-
ila and one researcher in National Institute for Health
and Welfare (THL), Finland. Part of the processing of
GIS data was performed by a GIS expert in School of
Economics, Aalto University, Finland. Totally this work
needed 65 person-months to be completed.
Data validation and monitoring
The GIS officer in Bohol made all corrections in the
data and she sent the corrected data to RITM. The GIS
Table 1 Distribution of the various landmark types in the
study area
Landmark Number (%)
N = 1,982
Administrative 340 (17.15)
Barangay hall 109 (5.50)
Fire station 1 (0.05)
Government/Private office 13 (0.66)
Municipal office 4 (0.20)
NAPOCOR (National Power Corporation) 1 (0.05)
Prison 2 (0.10)
Purok (Zone) 210 (10.60)
Commercial 319 (16.09)
Commercial building 34 (1.72)
Daily supply 115 (5.80)
Hardware/construction supply 30 (1.51)
Health related 9 (0.45)
Hotel/resort/Lodge/Inn 36 (1.82)
Special 37 (1.87)
Transportation distributor 58 (2.93)
Education 226 (11.40)
Convent/Seminary/Monastery 5 (0.25)
Daycare center 36 (1.82)
Orphanage 1 (0.05)
Reservoir 8 (0.40)
School 72 (3.63)
Sports field 104 (5.25)
Health service 775 (39.10)
Barangay health station 48 (2.42)
Doctor’s house 1 (0.05)
Hospital 8 (0.40)
Pharmacy 1 (0.05)
Private clinic 10 (0.50)
Sari-sari store (Variety store) 639 (32.24)
Water refilling station 13 (0.66)
Water well 55 (2.77)
Religion 205 (10.34)
Cemetery 7 (0.35)
Church/Chapel/Worship 198 (9.99)
Transport 117 (5.90)
Bridge 10 (0.50)
Harbor 1 (0.05)
Plaza 2 (0.10)
Terminal 4 (0.20)
Waiting shed 100 (5.05)
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t h r e ed a t af i l e sw e r ep r o d u c e df o re a c hb a r a n g a y :o n e
for the household waypoints, one for the landmarks and
one for the roads. For the merging, GPSbabel http://
www.gpsbabel.org/ and EasyGPS http://www.easygps.
com software were used. The GIS officer also trans-
formed the GIS data into a SAS (SAS Institute Inc.)
dataset to check for possible queries and problems in
the waypoints. In case of such problems, she submitted
the data back to the field worker for correction and ver-
ification. Some queries included duplicate waypoints and
incorrect waypoint names. The correction process led to
the re-locating of the households and landmarks, re-
tracking of the roads and modification or deletion of the
collected waypoints. The merged and corrected data
were stored in GPS exchange (GPX) formats and were
sent from RITM to THL.
A random sample (67 subjects) was selected for a
quality control check to validate the household way-
points collected previously by the fieldworkers from the
5 municipalities (Dauis, Panglao, Baclayon, Cortes and
Balilihan). This random sample was taken from all col-
lected waypoints of each fieldworker and recollected.
The RITM GIS officer visited the study area to obtain
feedback from the field workers and to verify queries
from previously submitted waypoints.
Spatial data
The raw version of the GIS data was not suitable for
analysis as such and required major processing. This
process is described below.
Road network
We used the Arc/Info Workstation for preparation of
the geographic data and calculation of the distance
metrics. The GPS-based data, recorded as geographic
coordinates with decimal degrees, were imported to the
Arc/Info and projected to UTM zone 51 projection. The
most demanding task in post-processing of the data was
required for cleaning of the road network tracks. The
data contained multiple overlapping tracks as well as
errors due to poor signal, such as gaps or road intersec-
tions, where the tracks did not actually cross.
First, a large number of overlapping tracks were
deleted from the network. We then artificially
increased the spatial resolution of the tracks by intro-
ducing additional points into the lines for every 10 m.
To get a preliminary version with most intersections
correctly modeled, we cleaned the road layer with a
fuzzy tolerance of 5 m, which effectively collapsed all
points within the tolerance into a single point. Most
gaps were then closed by testing, whether there was
any intersecting line within 20 m from the end points
of any line, which was not connected to any other line
(a dead end).
Many of the roads in the study area were recorded in
both directions. The distance between separate lanes in
addition to the GPS accuracy, resulted in two parallel
lines, which in some cases were further apart than the 5
m tolerance. We converted the road layer to a raster
dataset with a cell size of 1 m. An iterative loop of
expanding and thinning the road areas was applied to
collapse the separate parallel lines to a single centerline
representing roughly the weighted average of the origi-
nal GPS tracks. This raster dataset was re-vectorized
and the intersection node points were snapped to the
intersection points of the pre-rasterization layer.
A total of 17 gaps or other errors were too large to fit
within the tolerances of the automated cleaning process
and needed to be edited manually. To reduce the
remaining measurement noise, we generalized the road
network using the shape preserving Douglas-Peucker
algorithm [9]. Finally, the topology of the road network
was built and checked. The result was a fully connected
GIS dataset that could be used for route optimization
and calculation of the true network distances. The final
results were manually checked and corrected by using
available satellite images and maps.
Study subjects and network analysis
The GIS point layers were created from the GPS data,
containing the locations of homes of the study subjects
and the landmarks classified in 60 classes (Table 1).
Each point in the data includes the latitude and longi-
tude coordinates as well as the ID and type of the point.
We calculated the closest location along the road line
for every object of the point layers, effectively connect-
ing the points to the road network.
To overcome problems in the poor altitude resolution
of the GPS data, we selected to use the ASTER GDEM
1
digital elevation model to discover the elevation of the
homes of the study subjects. We overlaid the point data-
base of the study subjects on the elevation model within
the Arc/Info GRID-module and added the elevation as
an attribute to the point database.
For all study subjects, we identified the closest land-
mark of importance. This was calculated on multiple
levels of the health facilities and public gathering places
with the Arc/Info Allocate command, which utilized the
road layer for true network distances. The study area
consists of two islands connected by two bridges creat-
ing a geographic setting, where the use of the Euclidean
measurements for the analysis would be justified only
over short distances.
Spatial relationships
The immediate surroundings of every study subject were
analyzed from two separate points of view by utilizing
Euclidean distances. First, we used the buffer radii of 10,
100, 250, 500, 1000 and 2000 m within which we calcu-
lated the numbers of the 11PCV and placebo recipients
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numbers of 11PCV and placebo recipients that had been
born before the subject in question was born. We also
recorded the number of landmark objects as a proxy for
the level of services available. For the purpose of nor-
malization, each buffer zone was intersected by the
shore line and the remaining land area was recorded.
Secondly, for each study subject we identified and calcu-
lated the distance to the closest 11PCV and placebo
recipient without any cut-off distance.
Results
The original study population consisted of 12,771 chil-
dren living in 10,607 households (Table 2). There were
8565 (80.7%) households with one child belonging to
study population, 1923 (18.1%) households with 2 chil-
dren, 116 (1.1%) households with 3 children and 3
(0.0%) households with 4 children, respectively.
A total of 13,208 locations (waypoints) were collected
with 12,383 at birth (93.8%), 799 (6.0%) at the age of 2
years and 26 (0.2%) transients or those who moved
away before reaching the age of 2 years (Figure 1). We
did not find the place of residence at birth for 383 chil-
dren and at the age of 2 years for 992 children. Reasons
for not collecting these locations were as follows: 1) not
found at birth; 2) lived elsewhere in Bohol at birth; 3)
lived outside Bohol at birth; 4) not found at 2 years of
age; 5) lived elsewhere in Bohol at 2 years of age; 6)
lived outside Bohol at 2 years of age; and 7) died before
2 years of age.
Out of the 67 subjects selected for the quality check,
in 57 (85.1%) cases the re-located and the original loca-
tions were in good agreement. In 7 (10.4%) cases, same
l o c a t i o n sw e r er e c o r d e da tb i r t ha n da tt h ea g eo f2
years in original collection while upon random checking
different waypoints were collected at birth and at the
age of 2 years. There were 3 occasions where different
waypoints at birth and at the age of 2 years were origin-
ally collected, but according to checking child had the
same place of living at birth and at the age of 2 years.
One location recollected at birth was 430 m from the
original one and the remaining 66 less than 100 m from
the original (Figure 2).
We also collected 1982 landmarks. The landmarks
were categorized into 60 types (Table 1). These can be
grouped to six main types, namely the health services
(775 (39.10%)), the educational (226 (11.40%)), the com-
mercial (319 (16.09%)), the religion-related (205
(10.34%)), the transport (117 (5.90%)) and the adminis-
trative (340 (17.15%)) landmarks (Table 1 and Figure 3).
The sari-sari or variety stores (belonging to the com-
mercial landmarks) are the main source of antibiotics
that are available without prescription.
There were 858 tracks in the original GPS data with
129,000 coordinate points. The total length of the origi-
nal tracks was 1411 km. The length of processed final
road network was 640 km.
The road network-based distance from the households
of the study subjects to different services were grouped
by the type of service (health services) or by the user of
service (mother, older sibling, study subject). The med-
ian distance to the nearest sari-sari store was 212 m
(range 0-6742 m, N = 5927) for the 11PCV recipients
and 218 m (range 0-6811 m, N = 5905) for the placebo
recipients. The median distance to nearest school (for
possible older sibling) was 835 m (range 0-7284, N =
5927) for the 11PCV recipients and 813 m (range 0-
6476 m, N = 5905) for the placebo recipients. All dis-
tances were positively skewed. The dense population in
Tagbilaran City and its immediate surroundings with
many services available produced many short distances,
while fewer people living in remote areas had mostly
long distances to many of these services.
For each child in the core trial, we determined the
numbers of 11PCV and placebo recipients in a sequence
of circular buffers with different radii around the house-
hold location at birth. Within a buffer of 500 m around
the location of a study participant’s household at birth,
Table 2 Characteristics of the six municipalities by land area, population (year 2000) and number of study children
enrolled in the study.
Characteristics Tagbilaran Dauis Panglao Baclayon Cortes Balilihan Total
Land area (in km
2) 30.61 42.88 55.37 34.02 43.77 150.22 356.87
Total population 77, 700 26, 415 21,337 14,996 12,702 16,837 169,987
PNF13 and EPI children enrolled 6,102 2,259 1,564 846 926 1,074 12,771
Waypoints collected
Households
At birth 5,784 2,234 1,551 835 919 1,060 12,383
Different at 2 years old 437 101 45 46 77 93 799
Transient 7 6 1 1 6 5 26
Landmarks 624 607 260 102 191 198 1,982
For each municipality there are the numbers of household locations, where the study children were born, and the number of household locations where the
study children were living at the age of 2 years. Transient children (not permanently living in area) were separately counted
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Figure 1 The locations of households at birth (12,383) in the study area Background map: www.openstreetmap.org.
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Figure 2 Random checking of 67 household waypoints at birth.
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5905) recipients were 0-328 (median 41) and 0-326
(median 41), respectively.
Discussion
The ARIVAC trial was conducted from 2000 to 2004
and the geographic locations of the households of the
participants in the core study were collected from 2008
to 2009. Although there was a 4 years gap, the collec-
tion of geographic locations was successful. This was
mainly due to the good bookkeeping of BHS, good local
knowledge of the BHS staff and the efficient communi-
cation of the fieldworkers in the neighborhood of the
household of the presumed study child. After 4 years,
99% of families were still living in the same location as
during the ARIVAC trial. The impact of new or changed
services is unknown, but at least health services had not
had essential changes during a 4 years gap between the
completion of the ARIVAC trial and the collection of
geographic data. Neither was any major change in the
road network known to have occurred. The results
showed that the data on geographic locations collected
afterwards is reliable and fairly comprehensive.
The landmarks and the road network were easy to
collect, while the collection of the household waypoints
by the fieldworkers was more laborious. There were no
decent maps available prior to data collection and no
data could be digitized from the maps [10]. To make
these new data available for the local community, all
landmarks and the processed road network were
donated to the OpenStreetMap project (see http://www.
openstreetmap.org/?lat=9.6749&lon=123.9253&-
zoom=12&layers=M and http://wiki.openstreetmap.org/
wiki/Talk:WikiProject_Philippines/Data_import_Arivac_-
Bohol). This made it possible to obtain a good roadmap
of the area for free public use.
The GIS methods make possible the informative visua-
lization of objects or events, such as clustering of dis-
eases, variations in local vaccine coverage or population
density. These visualizations might be valuable starting
points for various preliminary analyses and useful ways
to present the results of spatial analyses [11,12]. Maps are
often much more understandable for laymen than large
tables and thus more useful for policy-making [13].
Our approach makes it possible to measure the spatial
characteristics on an individual level. It also makes
 
Figure 3 Distribution of the landmarks and road network in the study area Background map: www.openstreetmap.org.
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ters of the bacteria separately in the neighborhood of
each study subject. In addition, connections of the
households to relevant services (such as schools and
shops) are possible with a distance metric. Thus, we can
for instance estimate which families share the same ser-
vices. By adding times of different events to these data,
it is possible to analyze spatio-temporal processes with
accurate data.
The spatial data were collected 5 years after original
study. Services and road network have some expanded
from the time of original study. Not all small roads were
collected and many paths are missing. In spite of these
limitations we believe that this data are fairly accurate
and comprehensive and one of the largest collected in
this kind of study.
Conclusions
The collection of geographic locations in intervention
trials could help to analyze and better understand spatial
factors. The results of public health research may highly
depend on spatial relationships among the study sub-
jects and between the study subjects and the environ-
ment, both natural and infrastructural [1,14].
Endnotes
1ASTER GDEM digital elevation model is the property
of Japan’s Ministry of Economy, Trade and industry
(METI) and NASA
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